SRR1073755
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR612311 | GTEX | — | 0.974 |
| 2 | SRR1468403 | GTEX | — | 0.938 |
| 3 | SRR1079168 | GTEX | — | 0.920 |
| 4 | SRR1387989 | GTEX | — | 0.911 |
| 5 | SRR1323807 | GTEX | — | 0.910 |
| 6 | SRR1464411 | GTEX | — | 0.903 |
| 7 | SRR1402840 | GTEX | — | 0.903 |
| 8 | SRR1368856 | GTEX | — | 0.895 |
| 9 | SRR1350525 | GTEX | — | 0.891 |
| 10 | SRR602871 | GTEX | — | 0.891 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 27 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.506 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.497 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.477 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.463 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.452 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.429 | Remibrutinib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.411 | Idelalisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.370 | Idelalisib | — uncovered |
| COAGULATION | 0.369 | Binimetinib | — uncovered |
| COMPLEMENT | 0.343 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.317 | Remibrutinib | — uncovered |
| APOPTOSIS | 0.303 | Idelalisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.220 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.217 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.210 | Inavolisib | — uncovered |
| P53_PATHWAY | 0.147 | Idelalisib | — uncovered |
| HYPOXIA | 0.134 | Idelalisib | — uncovered |
| ANDROGEN_RESPONSE | 0.126 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.119 | Inavolisib | — uncovered |
| HEME_METABOLISM | 0.106 | Temsirolimus | — uncovered |